- Scrip Originals
- Featured Topics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Schafer-N ApS
Pharmaxon aims to control cell mobility to fight disorders of the central nervous system and cancer. For glioblastoma, it has developed a neural cell mobility inhibitor that blocks cell migration in vitro and limits glioblastoma proliferation in animal models.
- Large Molecule
- Synthesis Technologies, Production Processes